ArticleBioengineering (Basel, Switzerland)2023
Artificial Hummingbird Algorithm with Transfer-Learning-Based Mitotic Nuclei Classification on Histopathologic Breast Cancer Images.
Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Quadra Sense: A Fusion of Deep Learning Classifiers for Mitosis Detection in Breast Cancer Histopathology.Diagnostics (Basel, Switzerland) · 2026Article
- Transferable deep learning with coati optimization algorithm based mitotic nuclei segmentation and classification model.Scientific reports · 2024Article
- Enhanced Pelican Optimization Algorithm with Deep Learning-Driven Mitotic Nuclei Classification on Breast Histopathology Images.Biomimetics (Basel, Switzerland) · 2023Article
- Mitotic Nuclei Segmentation and Classification Using Chaotic Butterfly Optimization Algorithm with Deep Learning on Histopathology Images.Biomimetics (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Recently, artificial intelligence (AI) is an extremely revolutionized domain of medical image processing. Specifically, image segmentation is a task that generally aids in such an improvement. This boost performs great developments in the conversion of AI approaches in the research lab to real medical applications, particularly for computer-aided diagnosis (CAD) and image-guided operation. Mitotic nuclei estimates in breast cancer instances have a prognostic impact on diagnosis of cancer aggressiveness and grading methods. The automated analysis of mitotic nuclei is difficult due to its high similarity with nonmitotic nuclei and heteromorphic form. This study designs an artificial hummingbird algorithm with transfer-learning-based mitotic nuclei classification (AHBATL-MNC) on histopathologic breast cancer images. The goal of the AHBATL-MNC technique lies in the identification of mitotic and nonmitotic nuclei on histopathology images (HIs). For HI segmentation process, the PSPNet model is utilized to identify the candidate mitotic patches. Next, the residual network (ResNet) model is employed as feature extractor, and extreme gradient boosting (XGBoost) model is applied as a classifier. To enhance the classification performance, the parameter tuning of the XGBoost model takes place by making use of the AHBA approach. The simulation values of the AHBATL-MNC system are tested on medical imaging datasets and the outcomes are investigated in distinct measures. The simulation values demonstrate the enhanced outcomes of the AHBATL-MNC method compared to other current approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.